chemistry in the news

Here's a link to an article from Science Daily about a new molecule that was developed and will hopefully lead to a treatment for Myotonic Dystrophy Type I.  Currently there is no treatment for this disease, which is the most common type of muscular dystrophy in adults.  In this disorder, a mutation causes RNA to bind to an important protein found in the cell nucleus.  This new molecule, which was developed at the University of Illinois by Steven Zimmerman and his group, causes the RNA to "let go" of the protein, which breaks up the nuclear clusters. 

Here's the link:

http://www.sciencedaily.com/releases/2013/05/130501145107.htm